DIAMOND THERAPEUTICS INC.

Diamond Therapeutics is a clinical-stage drug development company focused on non-hallucinogenic, psychedelic-based therapies for use in the treatment of mental health. They are developing safe, FDA, EMA and Health Canada approved therapies for neuropsychiatric conditions, starting with sub-perceptual psilocybin-based medicines. Diamond Therapeutics is a Toronto-based company founded in 2018 with the mission to develop new and better drugs for mental health conditions by unlocking the promise of psychedelic compounds. Diamond is focused on sub-perceptual, non-hallucinogenic take-at-home prescription treatments that hold potential for use across a broad patient cohort —maximizing the positive impact better drugs can have on global mental health.